A Randomized, Dose-Finding Study of Sphenopalatine Ganglion Block With Bupivacaine for Emergency Department Patients With Headache

Puntos clave

• Sphenopalatine ganglion block significantly reduces headache pain, offering a new intervention option.
• Patients receiving the block experienced a 50% reduction in pain within 30 minutes post-procedure.
• This dose-finding randomized study evaluated various doses of bupivacaine in a controlled setting.
• Further investigation is necessary to confirm these findings in broader populations and different settings.